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Abstract. Caveolae undergo a cyclic transition from a 
flat segment of membrane to a vesicle that then returns 
to the cell surface. Here we present evidence that this 
cycle depends on a population of protein kinase C-et 
(PKC-a) molecules that reside in the caveolae mem- 
brane where they phosphorylate a 90-kD protein. This 
cycle can be interrupted by treatment of the ceils with 
phorbol-12,13-dibutyrate or agents that raise the con- 
centration of diacylglycerol in the cell. Each of these 
conditions displaces PKC-~x from caveolae, inhibits the 
phosphorylation of the 902kD protein, and prevents in- 
ternalization. Caveolae also contain a protein phos- 
phatase that dephosphorylates the 90-kD once PKC-a 
is gone. A  similar dissociation of PKC-c~ from caveolae 
and inhibition of invagination was observed when cells 
were treated with histamine. This effect was blocked by 
pyrilamine but not cimetidine, indicating the involve- 
ment of histamine H 1 receptors. These findings suggest 
that the caveolae internalization cycle is hormonally 
regulated. 
T 
HE caveola (47) is a membrane domain specialized 
for transcytosis (27) and endocytosis (3). The inter- 
nalization process occurs in a cycle that begins with 
membrane invagination. The invaginated membrane then 
closes to form a compartment designated a plasmalemmal 
vesicle (27). Eventually the plasmalemmal vesicle returns 
to  the  cell  surface  to  complete  the  cycle. The  glycosyl 
phosphatidylinositol (GPI)l-anchored folate receptor has 
provided important clues to the dynamics of caveolae in- 
ternalization (18-21). In MA104 cells, this receptor is in- 
ternalized by caveolae and returns to the cell surface in ~1 h. 
Throughout this period, a constant number (50%) of re- 
ceptors are maintained on the cell surface with an equal 
number remaining inside. 
We have found the caveolae cycle to be influenced by 
three conditions. First, culturing cells in the absence of a 
source of cholesterol markedly reduces the number of ca- 
veolae and inhibits folate receptor internalization (6). Sec- 
ond, treatment of cells with phorbol esters prevents the in- 
vagination  of  caveolae  without  affecting  the  return  of 
plasmalemmal vesicles to the cell surface (41). Third, ele- 
vation of cellular arachidonate levels with indomethacin 
blocks both plasmalemmal  vesicle formation and the re- 
turn of existing vesicles to the surface (40). These studies 
suggest that cholesterol is required for the structural integ- 
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rity of caveolae, but that there is a set of resident caveolae 
molecules in control of the internalization cycle. 
The internalization of the folate receptor by caveolae is 
an essential step in the potocytosis of 5-methyltetrahydro- 
folate (20, 31, 41). Recent biochemical and immunoelec- 
tron microscopic evidence now supports the view that ca- 
veolae also are important sites for compartmentalizing a 
variety of cell-signaling activities (1-3). Caveolae appear 
to be enriched in many different types of signaling mole- 
cules. These include:  (a)  GPI-anchored hormone recep- 
tors  (44);  (b)  inositol  1,4,5-trisphosphate  receptors  (13); 
(c) protein kinase C (PKC) (24); (d) lipid second messen- 
ger molecules such as sphingomyelin (4) and gangliosides 
(28, 46);  (e)  G  protein-coupled membrane receptors (8, 
10, 30); (f) multiple heterotrimeric GTP-binding proteins 
(7, 24); (g) nonreceptor tyrosine kinases (24, 38); and (h) 
an ATP-dependent Ca  2÷ pump (12). None of these mole- 
cules is found exclusively in caveolae, which suggests that 
they have a special function in this location that cannot be 
performed elsewhere in the cell. 
Signal  transduction in caveolae could be regulated by 
controlling the internalization cycle (1). The recent finding 
that PMA inhibits invagination (41) while the phosphatase 
inhibitor okadaic acid prevents the return of internalized 
vesicles to the cell surface (29) has focused our attention 
on PKC as a possible regulator. We now present morpho- 
logical and biochemical evidence that caveolae contain a res- 
ident population of PKC-~x. PKC-c~ phosphorylates a 90-kD 
protein in caveolae. Phorbol-12,13-dibutyrate (PDBu) and 
A1F4 prevent  folate  receptor  internalization  and  at  the 
same time stimulate the loss of PKC-a from caveolae. In 
the absence of the kinase the 90-kD protein becomes de- 
phosphorylated. Finally, stimulation  of histamine  H1  re- 
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PKC-a from caveolae. 
Materials and Methods 
Materials 
Medium 199 with Earle's salts minus folic acid was prepared by standard 
methods (18). FCS was from Hazleton Research Products, Inc. (Lenexa, 
KS).  Glutamine,  trypsin-EDTA, and  penicillin/streptomycin were from 
GIBCO-BRL (Gaithersburg, MD). The analytical  silica  gel  TLC plates 
and the following  solvents were from J. T. Baker, Inc. (Phillipsburg, NJ): 
heptane, petroleum ether, ethyl ether, acetic acid, and 2-propanol. Radio- 
labeled  adenosine-5-triphosphate  and  orthophosphate  were  obtained 
from DuPont Co. (Wilmington, DE) with specific activities  of ~6,000 and 
9,000 Ci/mmol, respectively.  The sulfuric-dichromate spray was from Su- 
pelco Inc. (Bellefonte, PA). Percoll  was from Pharmacia LKB Biotechnol- 
ogy Inc.  (Piscataway,  NJ).  [3H]folic acid  (sp act 27  Ci/mmol) was pur- 
chased from Moravek Biochemicals Inc. (City of Industry, CA). All PKC 
activators and inhibitors were purchased from Calbiochem-Novabiochem 
(San Diego, CA). Antibodies were obtained from the following sources: 
anti-caveolin  IgG (mAb 2234) was a gift from Dr. John Glenney (Glen- 
tech,  Inc., Lexington, KY); anti-clathrin IgG (mAb X-22) was a gift from 
Dr. Francis Brodsky (University of California,  San Francisco); goat anti- 
mouse IgG conjugated to peroxidase was from Organon Teknika (West 
Chester, PA); anti-PKC-a IgG (mAb) and anti-receptor for activated C 
kinase (RACK)I IgG (mAb) were from Transduction Laboratories (Lex- 
ington, KY); goat anti-mouse IgG (b2-6500)  and gold-conjugated rabbit 
anti-goat IgG were from Sigma Chemical Co., St. Louis, MO. [3H]acetate 
(4.13 Ci/mmol) was obtained from DuPont Co. Poly-L-lysine (P-1524) was 
from Sigma Chemical Co. 
Methods 
Cell Culture. The monkey kidney epithelial cell line,  MA104,  was grown 
as a monolayer in folate-free medium 199 supplemented with 5 % (vol/vol) 
FCS and 100 U/ml penicillin/streptomycin. Ceils for each experiment were 
set up according to a standard format. On day 0 cells  were seeded into 
T-25 (1.5 × 10  s cells) or T-75 (3 ×  105 cells) culture flasks and cultured for 
5 d without further feeding.  For folate-binding studies, the medium was 
replaced with folate-free M199 containing 20 mM Hepes (pH 7.4) without 
serum and additions were made directly  to the culture flasks. 
Caveolae Isolation. The caveolae  isolation procedure was a  modifica- 
tion of the method developed by Sargiacomo et al. (37). Five T-75 flasks 
of confluent cells (a total 10 mg protein) were used for each sucrose gradi- 
ent. Each flask was washed briefly with PBS at room temperature and the 
cells collected  by scraping with 5 ml of ice-cold  PBS. All subsequent steps 
were carried out at 4°C. The cells were pelleted in a table-top centrifuge 
for 5 rain at 1,400 g. Cells were resuspended with a pipette tip in 1.0 ml ly- 
sis buffer (0.25 M sucrose, 5 mM Hepes, pH 7.4). The samples were then 
dounced 15  times in a  1-ml tight Dounce homogenizer. The suspension 
was transferred to a 1.5-ml tube and centrifuged at 1,000 g for 10 min. The 
supernatant fractions were removed and stored on ice. The pellets were 
suspended in 1.0 ml lysis buffer, dounced, and centrifuged as described 
above. The supernatant fractions were combined and layered on top of 23 
ml of a 30%  Percoll  solution (in lysis buffer). The cell lysates were then 
centrifuged at 84,000 g for 30 min, in a Ti60 rotor (Ti60; Beckman Instru- 
ments, Inc., Fullerton, CA). The plasma membranes appeared as a visible 
band ~5.7 cm from the bottom of the Ti60 bottle. The liquid  above the 
plasma membranes was removed and the membranes collected  with a Pas- 
teur pipette. The volume of the plasma membranes was adjusted to 2.0 ml 
with lysis buffer and 200 ml 10% Triton X-100 was added to each sample 
giving a final Triton X-100 concentration of 1% and protein concentration 
of 0.6 mg. The mixtures were gently inverted several times and incubated 
on ice for 30 min. Linear sucrose gradients (10-30%) were prepared in 10 
mM Hepes (pH 7.4). The solubilized  membranes (vol, 2 ml) were layered 
on top of the gradients (vol, 11 ml). The samples were then centrifuged at 
143,000 g for 18-20 h. At the end of the centrifugation, the gradients were 
fractionated in 0.65-ml fractions and analyzed. 
Membrane Cholesterol Measurement. TLC was carried out as previously 
described (43). Five confluent T-75 flasks of MA104 cells were used for 
each sample. 75 txCi of [3H]acetate  was added to the culture media on day 
4 and cells were harvested on day 5. The cells were then washed exten- 
sively in PBS and placed in 3 ml of buffer (DMEM, 20 mM Hepes, pH 
7.4). The caveolae were then isolated on sucrose gradients. Each gradient 
fraction was adjusted to 1 ml final vol with PBS and adjusted to 30%  tau- 
rodeoxycholate. This sample was then mixed with 2 ml Dole reagent (78: 
20:2; 2-propanol/heptane/water) plus 1 ml of heptane. The samples were 
vortexed and spun in a table-top centrifuge for 10 min (3,000 g). The hep- 
tane phase (upper) contained neutral lipids  and was used for TLC. The 
aqueous phase (bottom) contained proteins and was used for immuno- 
blots. The heptane phase was dried under N 2 and suspended in 50 ixl of 
the solvent system (80:20:1; petroleum ether/ethyl ether/acetic acid).  To 
determine the position of cholesterol after chromatography, 5 txg unla- 
beled cholesterol was dissolved in the same solvent system and run as a 
standard. 1 Ixg unlabeled cholesterol was also added to each fraction from 
the gradient. The lipids were spotted onto a silica gel G plate and devel- 
oped in the solvent system. Lipids were visualized  by charring with sulfu- 
ric acid--dichromate  followed by heating at 180°C for 10 min. The appro- 
priate spots were scraped and the amount of radioactivity  was measured 
using liquid scintillation  counting. 
Electrophoresis and Immunoblots. Protein concentrations  were determined 
by D.C. assay (Bio-Rad Laboratories, Hercules, CA). Proteins were con- 
centrated by TCA precipitations and washed in acetone. Pellets  were sus- 
pended in Laemmli sample buffer and heated at 95°C for 3 min before being 
loaded  onto gels.  Proteins  were  separated  in  a  12.5% SDS-polyacryl- 
amide gel by the method of Laemmli (23). Proteins were then transferred 
to nylon membrane. The membrane was blocked in TBST (20 mM Tris, 
pH 7.6; 137 mM NaCI; 0.5%  Tween-20) plus 5% dry milk for 1 h at room 
temperature. Primary antibodies were diluted  in TBST  +  1%  dry milk 
and added to the incubation mixture for 1 h at room temperature. After 
the primary antibody incubation, the membrane was washed four times, 
10 rain each in TBST +  1% dry milk. The appropriate secondary antibody 
conjugated to HRP was diluted 1/30,000 and added to the incubation mix- 
ture for 1 h at room temperature. The membrane was then washed and 
processed to visualize  reactive proteins by the enhanced chemilumines- 
cence method. 
Alkaline Phosphatase Enzymatic Assay. A piece of nylon membrane was 
soaked in methanol for 1 min and then washed twice in PBS. 10 I~l of each 
fraction from the gradient was spotted on the membrane. The membrane 
was washed once in PBS  and developed using an alkaline  phosphatase 
substrate  kit  from Bio-Rad  Laboratories.  To  50  ml  of  alkaline  phos- 
phatase color development buffer we added 500 I~1 each of substrates A 
and B.  After mixing, we incubated the membrane in this reagent for 
5-30 min. The reaction was stopped by washing the membrane with dis- 
tilled water. 
Folate Receptor Internalization. The [3H]folic acid-binding assay was used 
to measure internal and external folate receptors as previously described 
(21). MA104 cells were subjected to the indicated treatments and then in- 
cubated in the presence of 5 nM [3H]folic acid (sp act 27 Ci/mmol) for 1 h 
at  37°C. External  [3H]folic  acid  corresponded to  the  amount released 
when cells  were incubated on ice for 30 s in the presence of acid  saline 
(0.15 M NaC1, adjusted to pH 3.0 with glacial acetic  acid).  Internal folate 
was the amount of [3H]folic acid that remained associated with the acid- 
saline-treated cells. The latter was collected  by adding 0.1 N NaOH to the 
flask to dissolve  the cells. Radioactivity was measured by liquid  scintilla- 
tion counting using a liquid  scintillation  analyzer (Tri-carb 1900A; Pack- 
ard  Instruments Co.,  Inc.,  Downers Grove,  IL).  Nonspeciflc  binding, 
which was measured by adding 100-fold  excess unlabeled folic  acid, was 
<5% of specific binding. 
Phosphorylation Assay. For the in vivo phosphorylation assays, MA104 
ceils were grown under standard conditions. Five T-75 flasks  were used 
for each sample. Each flask was washed three times with 10 ml of Krebs- 
Ringer bicarbonate, pH 7.4 (KRB). Cells were then incubated in 20 ml of 
KRB for 60 min, 37°C. The KRB was removed and 6 ml fresh KRB con- 
taining 1 mCi of [32p]orthophosphate (sp act 9,000 Ci/mmol) was added to 
each flask and the cells were incubated for 60 min at 37°C. The cells were 
then subjected to the indicated treatments. At the end of the treatment, 
the flasks were washed three times with KRB and the plasma membrane 
caveolae isolated.  The proteins were resolved by SDS-PAGE and the ra- 
diolabeled proteins visualized  by autoradiography. 
For the  in vitro phosphorylation assays, caveolae  were prepared  by 
standard methods (fractions 5, 6, and 7) on sucrose gradients and the fol- 
lowing components were added:  20 mM Hepes, pH 7.4; 5 mM MgC12; 1 
mM MnClz; 10 mM unlabeled ATP; 10 txCi [-/-3zP]ATP (0.13 /xM, sp act 
6,000 Ci/mmol). The mixture was then incubated for 15 min at room tem- 
perature. The reaction was stopped by TCA precipitation. Radiolabeled 
proteins were detected by autoradiography after electrophoresis in 12.5 % 
polyacrylamide gels. 
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carried out as previously described (35). To localize caveolin, clathrin, and 
PKC-et, we used  the  whole mount,  plasma membrane  preparation  of 
Sanan and Anderson (36). The grids with adherent membranes were incu- 
bated 30 min each with the indicated primary antibodies (mAb 2234 di- 
luted 1/100; anti-PKC-ct IgG diluted 1A00;  mAb x-22 at 1 I.~g/ml),  followed 
by 50 txg/ml of goat anti-mouse IgG, and finally a 1:30 dilution of gold- 
conjugated rabbit anti-goat IgG. All the antibodies were diluted in PBS 
containing 0.15% BSA. The  grids were washed after  each incubation 
three times for 30 min in this mixture. After a final wash, grids were fixed 
with 2.5% glutaraldehyde in PBS for 10 min followed by 1%  osmium 
tetroxide in PBS for 10 min. The grids were stained sequentially for 10 
min each with 1% tannic acid, 1% uranyl acetate. All samples were exam- 
ined  and  photographed  with an  electron  microscope (100 CX; JEOL 
U.S.A. Inc., Peabody, MA). 
Results 
In the current studies we modified the procedure of Sargi- 
acomo  et  al.  (37)  to  isolate caveolae from  plasma mem- 
branes purified on Percoll gradients  (15).  Caveolae were 
isolated by separating the Triton X-100-insoluble and -sol- 
uble  components  of these  membranes  on  a  10--30%  su- 
crose gradient. Each fraction was assayed for the presence 
of three  molecules  that  previously have  been  shown  by 
morphological methods to be enriched in invaginated ca- 
veolae (Fig. 1): the 22-kD integral membrane protein, ca- 
veolin (34); the GPI-anchored membrane protein, alkaline 
phosphatase (17, 48); and cholesterol (39).  Fractions 5, 6, 
and 7  contained all of the detectable caveolin (Immuno- 
blot, Fig. 1) but only 1% of the total protein loaded on the 
gradient. These  same  fractions were  enriched in  alkaline 
phosphatase enzymatic activity (A.P., Fig. 1).  Soluble ac- 
tivity was also present in fractions 1, 2, and 3, which con- 
tained 95%  of the protein. Fractions 5, 6, and 7 contained 
6%  of the total plasma membrane cholesterol (m, Fig. 1), 
which  is an  approximately sixfold enrichment  relative to 
the plasma membrane. 
PKC-a Is in Caveolae 
We  used  immunoblotting  to  determine  if  the  caveolae 
fractions contained PKC-a. Equal amounts of protein (10 
txg)  from  each  fraction,  plus  an  aliquot  (10  Ixg)  of  the 
whole plasma membrane  (lane P, Fig. 2)  and the cytosol 
(lane C, Fig. 2), were separated by SDS-PAGE. Each sam- 
ple was then immunoblotted either with anti-caveolin IgG 
(anti-caveolin, Fig. 2) or anti-PKC-a IgG (anti-PKCce, Fig. 
2). The concentration of caveolin in the plasma membrane 
sample was not high enough to detect (lane P, Fig. 2) but it 
was easily visualized in the caveolae fractions 5, 6, and 7. 
The  PKC-et  concentration  in  whole  plasma  membranes 
was also too low to detect (anti-PKCa, lane P, Fig. 2). By 
contrast,  there  was  a  very strong  signal in  each caveolae 
fraction (anti-PKCa, lanes 5, 6, and 7, Fig. 2). PKC-a was 
also detected in the sample of cytoplasm (lane C, Fig. 2), 
consistent with it being an abundant cytosolic protein (16). 
Therefore, the only place in the plasma membrane where 
we detected PKC-c~ was in the caveolae fractions. 
To  rule  out  the  possibility that  PKC-a was  a  contami- 
nant of the caveolae fractions, we used immunogold to lo- 
calize the kinase in isolated plasma membranes. The flat- 
tened  morphology  of  normal  human  fibroblasts  make 
them better suited for this analysis than  the MA104 cell. 
Therefore, the upper membrane surface of these cells was 
attached to poly-L-lysine-coated electron microscope grids 
by the method of Sanan and Anderson (36) and processed 
to localize either caveolin (a-d, Fig. 3) or PKC-c~ (b and c, 
Fig. 3). Anti-caveolin IgG gold was exclusively associated 
with  numerous  dense  regions of membrane  that  had  the 
general  morphology  of  invaginated  caveolae  (Fig.  3  a). 
Structures that labeled with anti-PKC-a IgG gold had ex- 
actly the same morphology (Fig. 3 b). Clathrin-coated pits 
did not label with either one of these antibodies (arrows, 
Fig. 3, b  and d). Double labeling with a  rabbit anti-caveo- 
lin IgG  (5  nm  gold)  and  a  mouse  anti-PKC  IgG  (15  nm 
gold) showed  that the  two antigens were both present in 
the  same  membrane  structure  (Fig.  3  c).  Only  the  anti- 
caveolin IgG-gold (5 nm) labeling was seen when  a  non- 
Figure 1.  Characterization of Triton X-100-soluble and -insolu- 
ble plasma membrane.  Plasma membranes were  isolated from 
MA104 cells using a  30%  Percoll gradient and then  incubated 
with 1% Triton X-100 at 4°C. The sample was layered on the top 
of a 10-30% sucrose gradient (top is at the left) and soluble (frac- 
tions 1-3) and insoluble material (fractions 5-7) was separated by 
centrifugation. The gradient was fractionated and the concentra- 
tion  of  cholesterol  (11), caveolin  (Immunoblot),  and  alkaline 
phosphatase (A.P.) was measured in each fraction as described. 
Typically the caveolae-rich fractions were 5, 6, and 7 (arrows). 
These fractions contained < 1% of the total protein loaded on the 
gradient. 
Figure 2.  Localization of PKC-a in plasma membranes by immu- 
noblotting. MA104 cell plasma membranes were fractionated as 
described in Fig. 1. Equal amounts of protein from each fraction 
(1-12) plus samples of cytoplasm (C) and plasma membrane (P) 
were separated by electrophoresis and immunoblotted with ei- 
ther anti-caveolin IgG (anti-caveolin) or anti-PKC-a IgG (anti- 
PKC-a). 
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in plasma membranes by immu- 
nogold.  Whole  plasma  mem- 
branes  from  human  fibroblasts 
were attached to Formvar-coated 
electron  microscopy  grids  and 
immunogold stained using either 
(a)  mAb anti-caveolin IgG  (15 
nm gold), (b) mAb anti-PKC-~ 
IgG  (15  nm  gold),  (c)  rabbit 
anti-caveolin IgG  (5  nm  gold) 
plus  mouse  anti-PKC  (15  nm 
gold), or (d) rabbit anti-caveolin 
IgG  (5  nm  gold)  plus  nonim- 
mune mouse IgG (15 nm gold). 
Arrows indicate the location of 
clathrin-coated pits. a  and b are 
the  same  magnification  and  c 
and  d  are  the  same  magnifica- 
tion. Bars, 0.45 Dxm. 
immune mouse IgG was substituted for the anti-PKC IgG 
(Fig. 3 d). 
Inhibitors  of Caveolae Internalization  Displace PKC-a 
from Caveolae 
Fig. 4  shows the effect that PDBu  has on folate receptor 
internalization and on the presence of PKC-c~ in caveolae. 
Cells were incubated in the presence (PDBu, Fig. 4 A) or 
absence (NT, Fig. 4 A) of i  ixM PDBu for 1 h  before mea- 
suring the internal (R) to external (L) folate receptor ra- 
tio. PDBu caused a 70% decline in this ratio by preventing 
receptor internalization. After we removed  the  drug and 
incubated the cells an additional 3.5 h (wash-out, Fig. 4 A), 
the receptor ratio returned to control values. Triton X-100- 
treated  plasma  membranes  from  a  replicate  set  of cells 
were  then  fractionated  on  a  sucrose  gradient  and  each 
fraction was blotted with  an  anti-PKC-ct IgG (Fig. 4  B). 
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Figure 4.  The effect of PDBu and A1F4 on potocytosis  (A) and 
the  distribution  of  either  PKC-a  (B)  or  caveolin  (C)  in  the 
plasma membrane. Either potocytosis was measured (A) or frac- 
tions  of Triton X-100-treated plasma membranes from the su- 
crose gradients  were immunoblotted (B and C) in cells incubated 
in the presence of media alone (NT); 1 ~M PDBu (PDBu); 10 
txM AICI3 plus 10 mM NaF (AlF4); or PDBu followed by 3.5 h in 
the absence of the drug (wash-out). For the immunoblots,  each 
lane contained an equal amount of protein (10 i~g/ml). Each lane 
corresponds to the indicated  fraction number and lanes C and P 
(B) are equal protein loads of cytoplasm and plasma membrane, 
respectively. 
Nontreated cells had a prominent PKC-ct band in the ca- 
veolae fractions (NT, 5, 6, and 7, Fig. 4 B) and in the sam- 
ple of cytosol (C, Fig. 4 B). PDBu-treated cells (PDBu, Fig. 
4 B), by contrast, did not have detectable PKC-et in any of 
the  fractions,  indicating  that  it  was no longer associated 
with the  plasma membrane. The PKC-ct returned  to the 
caveolae fraction after the  drug was removed (wash-out, 
Fig. 4 B). The distribution of caveolin in the sucrose gradi- 
ent was not altered in PDBu-treated cells (Fig. 4 C). 
While screening agents that affect caveolae internaliza- 
tion, we found that AIF4 was also a potent inhibitor of in- 
ternalization.  Fig.  4  (AIF4, Fig.  4  A)  shows  that  A1F4, a 
general activator of heterotrimeric GTP-binding proteins 
(5), was as effective as PDBu at blocking folate receptor 
internalization.  This treatment also stimulated the loss of 
PKC-ct from the caveolae fractions (AIF4, 5, 6, and 7, Fig. 4 
C).  Unlike PDBu, however, there  was an increase in the 
amount of PKC-a bound to the plasma membrane (com- 
pare P in control with P in A1F4, Fig. 4 B). All of the addi- 
tional PKC-c~ was in the soluble material at the top of the 
gradient (AIF4, 1 and 2, Fig. 4 B). The distribution of cave- 
olin was not affected (compare NT with A1F4, Fig. 4  C). 
Cholera toxin, which activates the Gaccoupled adenylate 
cyclase  but  not  the  Gtxq-COupled  phospholipase  CI3, did 
not have any effect on caveolae function (data not shown). 
Therefore, two conditions that prevent caveolae internal- 
ization displace PKC-a from caveolae. 
PKC-a Phosphorylates a 90-kD Substrate in Caveolae 
We next looked for PKC-cx substrates in caveolae. MA104 
cells  were  incubated  in  the  presence  of  [32p]orthophos- 
phate (1 mCi/ml) for 1 h before fractionating Triton X-100-- 
treated plasma membranes on a sucrose gradient. Autora- 
diographic analysis of polyacrylamide gels from each frac- 
tion showed that the caveolae fractions contained a heavily 
phosphorylated, 90-kD protein (NT, Fig. 5 A; see Fig. 7 for 
an autoradiogram of the whole gel). We did not detect this 
protein in any other fraction. We could not detect this pro- 
tein in caveolae fractions if the cells were treated with ei- 
ther PDBu (PDBu, Fig. 5 A) or A1F4 (AIF4, Fig. 5 A) be- 
fore  processing  for  32p  incorporation.  The  subsequent 
removal of the PDBu from the media resulted in the re- 
turn of the 32p-labeled band to caveolae (wash-out, Fig. 5 A). 
We  prepared  isolated  caveolae  to  determine  if  they 
could support the phosphorylation of the 90-kD protein in 
vitro.  Cells were  incubated  under  various conditions  be- 
fore  we  separated  Triton  X-100-treated  plasma  mem- 
branes on a sucrose gradient (Fig. 5 B). We then incubated 
each fraction in the presence of 10 i~Ci/ml of [32p]ATP for 
15 rain. In control cells, autoradiography detected the 90- 
kD  phosphoprotein  only in  the  caveolae  fractions  (NT, 
Fig.  5 B).  This phosphoprotein was not seen in caveolae 
fractions prepared from cells that were exposed to either 
PDBu (PDBu, Fig. 5 B) or A1F4 (AIF4, Fig. 5 B). When we 
removed  the  PDBu  from treated  cells,  the  caveolae  re- 
gained  the  ability  to  phosphorylate  the  90-kD  protein 
(wash-out, Fig. 5 B). 
The isolated caveolae were used to verify that the 90-kD 
protein was a  PKC-ot substrate (Fig. 5  C). Caveolae frac- 
tions were prepared from control (NT, Fig. 5  C) and ex- 
perimentally treated  cells  (PDBu, AIF4, wash-out, Fig.  5 
C). We then used [32p]ATP to measure the phosphoryla- 
tion of the  90-kD protein after adding either a  PKC-ct- 
specific  inhibitor  or  purified  PKC-cx  to  the  reaction 
mixture.  Without  any  additions  the  90-kD  protein  was 
phosphorylated (Buffer, Fig. 5 C) in caveolae from control 
and  wash-out  cells,  but  not  from  cells  that  had  been 
treated  with  either  PDBu  or  AIF4.  The  addition  of the 
PKC-specific  inhibitor  peptide  (22)  completely  blocked 
phosphorylation in caveolae from control cells and wash- 
out cells (Inhibitor Peptide, Fig. 5 C). By contrast, the ad- 
dition of purified PKC ct (PKCa, Fig. 5 C) stimulated the 
phosphorylation of the 90-kD protein in the caveolae frac- 
tions from both PDBu- and A1F4-treated cells. Thus, the 
90-kD protein is a  PKC-a substrate that is not displaced 
from caveolae when cells are incubated in the presence of 
either PDBu or A1F4. 
Phosphorylation of 90-kD Protein Is Linked to 
Caveolae Invagination 
To link more firmly the activity of PKC-a to caveolae in- 
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vitro (B and C) phosphoryla- 
tion of a caveolae substrate. 
(A)  Cells  were  first  incu- 
bated  in the presence of or- 
thophosphate 32p for 1 h and 
then either not treated (NT) 
or  incubated  further  in  the 
presence  of PDBu  (PDBu), 
A1F4 (AIF4), or  PDBu  fol- 
lowed by 3.5 h in the absence 
of the  drug  (wash-out). Tri- 
ton  X-100-treated  plasma 
membranes  were  fraction- 
ated  on  sucrose  gradients, 
separated  by  electrophore- 
sis,  and  exposed  for autora- 
diography  (2  h).  (B)  Cells 
were either not treated (NT) 
or incubated in the presence 
of  PDBu  (PDBu),  AIF4 
(AIF4), or PDBu followed by 
3.5  h  in  the  absence  of the 
drug (wash-out). Membranes 
were fractionated and each fraction was incubated in the pres- 
ence of 10 txCi of [32p]ATP for 15 rain  at room temperature. 
Each sample was then separated by electrophoresis and analyzed 
by autoradiography.  (C)  Cells  were incubated  under the  indi- 
cated conditions as described in A and B. The caveolae fractions 
from the sucrose gradient were collected and incubated in an in 
vitro phosphorylation assay buffer that contained no additions 
(Buffer), 10 fzM PKC-c~-specific inhibitor peptide (Inhibitor Pep- 
tide) or 0.25 U  of rat brain PKC-cc Samples were separated by 
gel electrophoresis and analyzed by autoradiography. 
PDBu, however, the intensity of the band declined.  After 
40 min the band was no longer present  even though the 
[32p]orthophosphate  remained  in  the  media  throughout 
the  incubation.  The  time  sequence  for the  complete  de- 
phosphorylation of the 90-kD protein corresponded to the 
time required for internal folate receptors to recycle back 
to the cell surface during potocytosis (21). 
We next used isolated caveolae to determine if they con- 
tain a resident phosphatase  (Fig. 7 B). The caveolae were 
first  incubated  in  the  presence  of [32p]ATP to  label  the 
PKC-a substrate  (see Fig. 5). We added excess unlabeled 
ATP to the reaction mixture to prevent further [32p]ATP 
incorporation and incubated the sample for the indicated 
time (Control, Fig. 7 B). Initially the 90-kD protein was la- 
beled (0, control, Fig. 7 B) but the intensity of the band de- 
clined rapidly after unlabeled  ATP was added. The band 
was no longer evident after 9 rain. The addition of 10 nM 
okadaic acid, a  serine/threonine  phosphatase  inhibitor,  to 
the reaction mixture inhibited the loss of phosphate  from 
the protein  (Okadaic  Acid, Fig. 7  B). These  data suggest 
that caveolae contain a protein phosphatase. 
Histamine Regulates Caveolae Invagination 
The  differential  response  of caveolae to A1F4 (an inhibi- 
tor) and cholera toxin (no effect) suggested that caveolae 
invagination  might  be  regulated  by  a  G%-coupled  hor- 
mone receptor. The histamine H1 receptor belongs to this 
class  of receptors.  Therefore,  we  measured  the  effect of 
histamine concentration on folate receptor internalization 
vagination, we had to rule out the possibility that PDBu it- 
self was an inhibitor. Therefore, we prepared PKC-a-defi- 
cient MA104 cells. Cells were first exposed to PDBu for 1 h 
to  target  the  destruction  of  the  kinase  (Fig.  4  B).  The 
PDBu was then removed and the cells were further incu- 
bated for 3.5 h in the presence of cycloheximide (CHX) to 
prevent the synthesis of PKC-a. PDBu-treated cells were 
unable  to  internalize  [3H]folic  acid  (compare  NT  with 
PDBu,  Fig.  6 A)  and  neither  PKC-e~  (compare  NT with 
PDBu, Fig. 6 B) nor the 90-kD phosphoprotein  (compare 
NT with PDBu, Fig. 6 C) were detectable in isolated cave- 
olae. The caveolae from PKC-c~-deficient cells also did not 
have any detectable  PKC-c~ (wash-out  + CHX, Fig. 6 B) 
or  phosphoprotein  (wash-out  +  CHX,  Fig.  6  C).  These 
cells were unable to internalize  [3H]folic acid (wash-out  + 
CHX,  Fig.  6  A),  indicating  that  inhibition  is  not  due  to 
PDBu alone.  CHX by itself had no effect on the associa- 
tion of PKC-a with caveolae or the ability of cells to inter- 
nalize  folate  (CHX,  Fig.  6,  A,  B,  and  C).  Furthermore, 
cells washed free of PDBu but not exposed to CHX were 
normal (wash-out, Fig. 6, A, B, and C). 
We took advantage of the fact that PKC-c~ is rapidly de- 
graded when cells are exposed to PDBu (data not shown) 
to determine if the 90-kD protein is dephosphorylated af- 
ter  PKC-a  leaves  Caveolae.  Cells  were  incubated  in  the 
presence  of [32p]orthophosphate  to label  the protein  and 
then  PDBu  was  added  to  the  medium  for various  times 
(Fig. 7 A). Initially the  90-kD substrate  was intensely la- 
beled  (time  0,  Fig.  7  A).  With  time  in  the  presence  of 
Figure 6.  The effect of PKC-a 
depletion on potocytosis (A) 
and  the  presence  of  either 
PKC-a (B) or the 90-kD phos- 
phoprotein  (C)  in  caveolae. 
Either  potocytosis was mea- 
sured (A), caveolae fractions 
were  immunoblotted  with 
anti-PKC-c~ IgG (B), or frac- 
tions  were  analyzed  for the 
presence of phosphoproteins 
(C). Cells  were incubated in 
the presence of media alone 
(NT);  1 IxM PDBu (PDBu); 
PDBu followed by 3.5 h in the 
absence  of the  drug  (wash- 
out); PDBu followed by 3.5 h 
without  PDBu  in  the  pres- 
ence of cycloheximide (wash- 
out + CHX); or 3.5 h in the 
presence  of  cycloheximide 
alone (CHX). 
The Journal of Cell Biology,  Volume 131, 1995  934 Figure 7.  Dephosphorylation of the caveolae, PKC-a substrate in 
vivo (A) and in vitro (B). (A) Cells were first incubated in the 
presence of orthophosphate 32p for 1 h to label phosphoproteins. 
PDBu (1 txM) was added to the dish and the cells were incubated 
for the indicated time. Caveolae were isolated, the proteins sepa- 
rated by gel electrophoresis, and analyzed by autoradiography. 
(B) Caveolae were isolated from MA104 cells and incubated in 
the in vitro phosphorylation mixture as described in Fig. 5. A 100- 
fold excess unlabeled ATP was added to the reaction mixture and 
each fraction was incubated for the indicated time in the presence 
(Okadaic Acid) or absence (Control) of 10 nM okadaic acid. The 
protein in each sample was separated by gel electrophoresis and 
analyzed by autoradiography. 
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(Fig. 8). We observed a  dose-dependent decline in recep- 
tor internalization (Fig. 8 A) without any change in the to- 
tal number of receptors. Maximum inhibition occurred at 
10  txM histamine  (,-~70%). This concentration was  as ef- 
fective as either PDBu  or A1F4 (see Fig. 4 A). Incubation 
for 30-45 min in the presence of histamine was required to 
reach maximum inhibition (Fig. 8 B). After 90 min of incu- 
bation, the inhibition of receptor internalization began to 
decline.  The  receptor internalization returned  to  normal 
after 105 min. The loss of inhibition was apparently due to 
histamine receptor desensitization (45). The histamine H1 
receptor  antagonist  pyrilamine  prevented  the  inhibitory 
effects of histamine (Table I) while the H2-specific blocker 
cimetidine had no effect. For some reason pyrilamine also 
caused an increase in the total amount of bound  [3H]folic 
acid (Table I). These results suggest that histamine H1 re- 
ceptors can regulate caveolae internalization. 
Fig. 8  C  shows that like PDBu and A1F4, histamine also 
caused a  loss of PKC-a from caveolae. Initially all of the 
detectable plasma membrane PKC-c~ was in the caveolae 
fractions (0 min, Fig. 8  C).  10 min after 10  IxM histamine 
was added to cells PKC-c~ appeared in the Triton X-100- 
Figure 8.  The effects of histamine on potocytosis (A and B) and 
the  distribution of PKC-c~ in  the  plasma  membrane  (C).  (A) 
MA104 cells were incubated in the presence of the indicated con- 
centration of histamine for 1 h and the internal to external folate 
receptor ratio was measured as described. (B) Cells were incu- 
bated in the presence of 10 IxM histamine for the indicated time 
and the folate receptor ratio was measured. (C) Cells were incu- 
bated in 10 IxM histamine for the indicated time. Plasma mem- 
branes were fractionated on sucrose gradients and equal amounts 
of protein from each fraction (1-12) were separated by gel elec- 
trophoresis. Each  fraction was  then  immunoblotted with  anti- 
PKC-c~ ]gG. 
soluble membrane fractions at the top of the gradient. At 
the same time, the kinase disappeared from the caveolae 
fractions (10 min, Fig. 8  C). More PKC-c~ was detected in 
the Triton X-100--soluble fractions after a  1-h incubation 
(60 min, Fig. 8  C),  indicating that  additional cytoplasmic 
PKC-a  was  recruited  to  the  membrane.  The  PKC-a  re- 
turned  to  the  caveolae fractions  after  2  h  of incubation 
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Ability of Histamine to Regulate Folate Receptor Sequestration 
Internal/ 
Treatment  Internal  External  external 
(pmol/mg protein)  (pmol/mg  protein) 
None  1.04  1.08  0.96 
Histamine  0.59  1.40  0.42 
Histamine + 
pyrilamine  1.45  1.48  0.98 
Histamine + 
cimetidine  0.61  1.43  0.43 
MAI04 ceils were incubated in the presence of 10 ~M histamine in the absence or 
presence (+) of either 1 izM pyrilamine or 1 IxM c imetidine for 1 h and then the inter- 
nal to external folate receptor ratio was measured as described. Neither pyrilamine nor 
cimetidine alone had any effect on the the internal to external folate receptor ratio. All 
values are the average of triplicate measurements. 
(120 min, Fig. 8 C). The distribution of caveolin was not af- 
fected by the hormone (data not shown). 
Histamine also reduced the number of invaginated cave- 
olae on the surface of MA104 cells (Fig. 9). Cells were sub- 
jected to the indicated treatments and then processed for 
immunogold  localization  of the  folate  receptor.  Control 
cells had normal numbers of caveolae (arrowheads, Fig. 9 
A  and Table II) and clusters of receptor-specific gold (ar- 
rows, Fig.  9 A  and Table II). Cells exposed to histamine 
for 1 h, by contrast, had few caveolae but the same number 
of receptor clusters (arrows, Fig. 9 B  and Table II). Nor- 
mal numbers of invaginated caveolae were present after 2 h 
of incubation  (arrowheads,  Fig. 9 C and Table II). Hista- 
mine, therefore, appears to inhibit caveolae invagination 
by removing PKC-c~ from caveolae membrane. 
Discussion 
Three independent lines of evidence support the view that 
PKC-~ is an integral component of the molecular mecha- 
nism responsible for caveolae invagination. First, both bio- 
chemical and morphological methods show PKC-a to be 
constitutively present in plasma membrane caveolae. Sec- 
ond, caveolae contain a  PKC-c~ substrate that appears to 
be phosphorylated and dephosphorylated during the cave- 
olae  internalization  cycle.  Third,  three  different  experi- 
mental treatments that cause the loss of PKC-c~ from cave- 
olae inhibit  internalization.  We have detected  PKC-a in 
caveolae isolated from normal human fibroblasts, MA104 
cells, rat 1 cells, and NIH 3T3 cells (data not shown). In 
addition,  we have found that PMA prevents caveolae in- 
vagination in MA104 cells, normal human fibroblasts, and 
NIH 3T3 cells (41 and data not shown). 
PKC-a and the protein phosphatase may be the key reg- 
ulatory molecules that control the caveolae internalization 
cycle. Initial invagination may require the phosphorylation 
of the 90-kD protein by PKC-c~. Although we do not know 
the identity of this substrate, it may be a molecule involved 
in changing the shape of the plasma membrane. Once the 
plasmalemmal vesicle has formed, the PKC-c~ kinase activ- 
ity declines.  The  90-kD  phosphoprotein  is then  dephos- 
phorylated by an okadaic acid-sensitive, resident protein 
phosphatase.  Since okadaic acid appears to block vesicle 
recycling after caveolae internalize cholera toxin (29), the 
dephosphorylation of the 90-kD protein may be required 
for the return of vesicles to the cell surface. 
The enzymatic activities of the phosphatase and the ki- 
nase appear to operate at opposite ends of the caveolae 
cycle. Therefore, they are likely targets for regulatory hor- 
mones. Histamine appears to be one such hormone. The 
H1  receptor is the  only member of the seven transmem- 
brane, histamine receptor family that uses Gc% to activate 
phospholipase  C-[3 (9,  45).  Histamine  might  be  acting 
through  H  1  receptors that are in caveolae since  Gctq  ap- 
pears to be enriched in this membrane domain (37). The 
hormone clearly stimulated the recruitment of PKC-c~ to 
the  plasma membrane  (Fig.  8  C),  which  is the  expected 
consequence of an increase in cellular diacylglycerol (DAG) 
(16).  Paradoxically the  increase  in  DAG also stimulated 
the loss of PKC-a from caveolae. Exactly how DAG can 
have these opposing effects on the membrane localization 
of PKC-c~ is not known. 
Caveolae could contain a membrane receptor for PKC-cc 
A high-affinity membrane-binding site has been identified 
that binds DAG/Ca2+-activated PKC (RACKs)  (26,  33). 
We  immunoblotted  fractions  from  the  sucrose  gradient 
with an anti-RACK IgG and observed a strong band of the 
correct molecular weight in the caveolae fraction (data not 
shown).  The  protein  was  also  abundant  in  the  soluble 
membrane fractions, suggesting  that it is in  noncaveolae 
membrane as well. If RACK is the molecule that targets 
PKC-a to caveolae, then somehow it recognizes endoge- 
nous  PKC-cc  Recently  we  found  that  isolated  caveolae 
contain diacylglycerol (25), which could serve to activate a 
portion of the cytoplasmic PKC-c~. 
We have proposed that an important function of caveo- 
lae is to compartmentalize signal transduction  at the cell 
surface (1). We think that this is an important mechanism 
for integrating many different sources of spatial and tem- 
poral information as the cell responds to an environmental 
stimulus. An important source of cellular information are 
the hormone receptors that reside in caveolae. These in- 
clude receptors for insulin (14), EGF (42), cholecystokinin 
(32), endothelin (8), and epinephrine (10,  30). Sometimes 
these  receptors  are  also  found  at  other  locations  in  the 
same cell. For example, cholecystokinin stimulates the in- 
ternalization of ~60%  of its receptors by coated pits and 
~20%  by caveolae (32).  The signaling activities of these 
two populations of receptors may be quite different. Fur- 
thermore,  those  signals  originating  in  caveolae have the 
additional feature that they can be modulated by changing 
the  sequestration  state  of the  receptor-ligand  complex. 
Hormonal inactivation of the protein phosphatase in cave- 
olae, for example, would trap the complex in plasmalem- 
mal vesicles thus potentially preserving the activity of the 
receptor for extended periods. In some cases, the hormone 
could act globally on all caveolae in the cell. Other times a 
neighboring cell might locally release a hormone and only 
affect a subpopulation of caveolae nearby. Each situation 
would have a different consequence for cell behavior. 
The two markers that are most often used to define ca- 
veolae are the characteristic invaginated morphology (47) 
and  the  presence  of caveolin  (34).  Recently we  showed 
that  in  human  fibroblasts  caveolin  is  not  a  permanent 
structural molecule of caveolae because it can move to the 
Golgi  apparatus  without  a  loss  of invaginated  caveolae 
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tamine on the distribution of 
folate receptors and caveolae 
in  MA104  cells.  Cells  were 
either not treated  (A) or in- 
cubated for 1 h  (B)  and 2 h 
(C) in the presence of hista- 
mine, The cells  were immu- 
nolabeled with anti-folate re- 
ceptor IgG and prepared for 
electron microscopy. Arrows 
indicate the position of folate 
receptor-specific  gold  clus- 
ters  on  the  surface  and  the 
arrowheads mark the caveo- 
lae. Bar, 0.5 Ixm. 
(43).  Rapid-freeze, deep-etch images of the plasma mem- 
brane show a characteristic coat structure  associated with 
both  invaginated  and  uninvaginated  membrane  (34),  yet 
normally all coats with this morphology appear to contain 
caveolin.  This suggests that  the flask-shaped  morphology 
is also not an invariant feature of caveolae. Now we have 
found  that  the  internalization  cycle  is  regulated.  This 
raises  the  possibility  that  in  many  cells  caveolae  mem- 
brane is present but not visible in thin section electron mi- 
Table II. The Effects of Histamine in the Number of  lnvaginated 
Caveolae and the Density of Anti-folate Receptor IgG 
No. of  No. of labeled  Gold/labeled 
Treatment  No. of clusters  caveolae  caveolae  caveolae 
None  176  131  92  4.27 
Histamine 
1 h  170  11  9  3.91 
Histamine 
2 h  t 73  92  62  4.11 
MAI04 cells were incubated in the presence of 10 p~M histamine for the indicated 
time. Cells were then processed to immunogold  label the folate receptor. Quantitative 
data was gathered from photographs  taken at random of each sample (48). 
croscopic images because it is not engaged in an internal- 
ization  cycle.  This  would  explain,  for  example,  why  in 
lymphocytes (11) very few invaginated caveolae can be de- 
tected, yet membrane with similar biochemical properties 
to caveolae can easily be isolated. This suggests that cave- 
olae  are  a  complex  membrane  domain,  defined  by  a 
unique  lipid  and  protein  composition,  with  many  tissue 
specific functions. These functions may or may not make 
use of the internalization cycle. 
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